Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?

Por Schneider, Jeffrey G., Khalil, Danny N.
Publicado no Breast Cancer Res Treat (2012)

Commercial Laboratory Testing of Excision Repair Cross-Complementation Group 1 Expression in Non-Small Cell Lung Cancer

Por Schneider, Jeffrey G., Farhadfar, Nosha, Sivapiragasam, Abirami, Geller, Matthew, Islam, Shahidul, Selbs, Elena
Publicado em 2014

A Retrospective Review of CyberKnife Stereotactic Body Radiotherapy for Adrenal Tumors (Primary and Metastatic): Winthrop University Hospital Experience

Por Desai, Amishi, Rai, Hema, Haas, Jonathan, Witten, Matthew, Blacksburg, Seth, Schneider, Jeffrey G.
Publicado no Front Oncol (2015)

Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Small Academic Hospital Experience

Por Factor, Oren B., Vu, Charles C., Schneider, Jeffrey G., Witten, Matthew R., Schubach, Scott L., Gittleman, Alicia E., Catell, Donna T., Haas, Jonathan A.
Publicado em 2014